Since activation of the CXCL12 pathway may promote cancer cell survival, invasion, and stem and/or tumor-initiating cell phenotype, blocking the CXCR4-CXCL12 pathway may be a valid strategy to target various components in solid tumors. This evidence concerns the gene CXCR4 and cancer.